External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry

被引:134
作者
Boucly, Athenais [1 ,2 ,3 ]
Weatherald, Jason [4 ,5 ]
Savale, Laurent [1 ,2 ,3 ]
de Groote, Pascal [6 ]
Cottin, Vincent [7 ]
Prevot, Gregoire [8 ]
Chaouat, Ari [9 ]
Picard, Francois [10 ,11 ]
Horeau-Langlard, Delphine [12 ]
Bourdin, Arnaud [13 ]
Jutant, Etienne-Marie [1 ,2 ,3 ,14 ]
Beurnier, Antoine [1 ,2 ,3 ]
Jevnikar, Mitja [1 ,2 ,3 ]
Jais, Xavier [1 ,2 ,3 ]
Simonneau, Gerald [1 ,2 ,3 ]
Montani, David [1 ,2 ,3 ]
Sitbon, Olivier [1 ,2 ,3 ]
Humbert, Marc [1 ,2 ,3 ]
机构
[1] Univ Paris Saclay, Sch Med, Le Kremlin Bicetre, France
[2] Hop Bicetre, AP HP, Dept Resp & Intens Care Med, Le Kremlin Bicetre, France
[3] Hop Marie Lannelongue, INSERM UMR S 999, Le Plessis Robinson, France
[4] Univ Calgary, Dept Med, Div Respirol, Calgary, AB, Canada
[5] Libin Cardiovasc Inst, Calgary, AB, Canada
[6] Univ Lille, Inst Pasteur Lille, Serv Cardiol, Inserm U1167,CHU Lille, Lille, France
[7] Univ Lyon 1, Hosp Civils Lyon, UMR754, IVPC,Natl Reference Ctr Rare Pulm Dis,INRAE, Lyon, France
[8] CHU Toulouse, Hop Larrey, Serv Pneumol, Toulouse, France
[9] Univ Lorraine, Fac Med Nancy, Dept Pneumol, Inserm UMR 51116,CHRU Nancy, Vandoeuvre Les Nancy, France
[10] Univ Bordeaux, Hop Cardiol Haut Leveque, Heart Failure Unit, Bordeaux, France
[11] Pulm Hypertens Expert Ctr, Bordeaux, France
[12] CHU Nantes, Hop Laennec, Serv Pneumol, Nantes, France
[13] Univ Montpellier, Dept Resp Dis, CHU Montpellier, Montpellier, France
[14] CHU Poitiers, Serv Pneumol, Poitiers, France
关键词
PORTOPULMONARY HYPERTENSION; CALCULATOR; 2.0; SURVIVAL;
D O I
10.1183/13993003.02419-2021
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction Contemporary risk assessment tools categorise patients with pulmonary arterial hypertension (PAH) as low, intermediate or high risk. A minority of patients achieve low risk status with most remaining intermediate risk. Our aim was to validate a four-stratum risk assessment approach categorising patients as low, intermediate-low, intermediate-high or high risk, as proposed by the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA) investigators. Methods We evaluated incident patients from the French PAH Registry and applied a four-stratum risk method at baseline and at first reassessment. We applied refined cut-points for three variables: World Health Organization functional class, 6-min walk distance and N-terminal pro-brain natriuretic peptide. We used Kaplan-Meier survival analyses and Cox proportional hazards regression to assess survival according to three-stratum and four-stratum risk approaches. Results At baseline (n=2879), the four-stratum approach identified four distinct risk groups and performed slightly better than a three-stratum method for predicting mortality. Four-stratum model discrimination was significantly higher than the three-stratum method when applied during follow-up and refined risk categories among subgroups with idiopathic PAH, connective tissue disease-associated PAH, congenital heart disease and portopulmonary hypertension. Using the four-stratum approach, 53% of patients changed risk category from baseline compared to 39% of patients when applying the three-stratum approach. Those who achieved or maintained a low risk status had the best survival, whereas there were more nuanced differences in survival for patients who were intermediate-low and intermediate-high risk. Conclusions The four-stratum risk assessment method refined risk prediction, especially within the intermediate risk category of patients, performed better at predicting survival and was more sensitive to change than the three-stratum approach.
引用
收藏
页数:12
相关论文
共 24 条
[1]   Application of the REVEAL risk score calculator 2.0 in the PATENT study [J].
Benza, Raymond L. ;
Farber, Harrison W. ;
Frost, Adaani E. ;
Ghofrani, Hossein-Ardeschir ;
Corris, Paul A. ;
Lambelet, Marc ;
Nikkho, Sylvia ;
Meier, Christian ;
Hoeper, Marius M. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 332 :189-192
[2]   Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension [J].
Benza, Raymond L. ;
Kanwar, Manreet K. ;
Raina, Amresh ;
Scott, Jacqueline V. ;
Zhao, Carol L. ;
Selej, Mona ;
Elliott, C. Greg ;
Farber, Harrison W. .
CHEST, 2021, 159 (01) :337-346
[3]   Predicting Survival in Patients With Pulmonary Arterial Hypertension The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies [J].
Benza, Raymond L. ;
Gomberg-Maitland, Mardi ;
Elliott, C. Greg ;
Farber, Harrison W. ;
Foreman, Aimee J. ;
Frost, Adaani E. ;
McGoon, Michael D. ;
Pasta, David J. ;
Selej, Mona ;
Burger, Charles D. ;
Frantz, Robert P. .
CHEST, 2019, 156 (02) :323-337
[4]   The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension [J].
Benza, Raymond L. ;
Gomberg-Maitland, Mardi ;
Miller, Dave P. ;
Frost, Adaani ;
Frantz, Robert P. ;
Foreman, Aimee J. ;
Badesch, David B. ;
McGoon, Michael D. .
CHEST, 2012, 141 (02) :354-362
[5]  
Boucly A, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00279-2018
[6]   Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension [J].
Boucly, Athenais ;
Weatherald, Jason ;
Savale, Laurent ;
Jais, Xavier ;
Cottin, Vincent ;
Prevot, Gregoire ;
Picard, Francois ;
de Groote, Pascal ;
Jevnikar, Mitja ;
Bergot, Emmanuel ;
Chaouat, Ari ;
Chabanne, Celine ;
Bourdin, Arnaud ;
Parent, Florence ;
Montani, David ;
Simonneau, Gerald ;
Humbert, Marc ;
Sitbon, Olivier .
EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (02)
[7]   Risk stratification and medical therapy of pulmonary arterial hypertension [J].
Galie, Nazzareno ;
Channick, Richard N. ;
Frantz, Robert P. ;
Gruenig, Ekkehard ;
Jing, Zhi Cheng ;
Moiseeva, Olga ;
Preston, Ioana R. ;
Pulido, Tomas ;
Safdar, Zeenat ;
Tamura, Yuichi ;
McLaughlin, Vallerie V. .
EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (01)
[8]   2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) [J].
Galie, Nazzareno ;
Humbert, Marc ;
Vachiery, Jean-Luc ;
Gibbs, Simon ;
Lang, Irene ;
Torbicki, Adam ;
Simonneau, Gerald ;
Peacock, Andrew ;
Noordegraaf, Anton Vonk ;
Beghetti, Maurice ;
Ghofrani, Ardeschir ;
Gomez Sanchez, Miguel Angel ;
Hansmann, Georg ;
Klepetko, Walter ;
Lancellotti, Patrizio ;
Matucci, Marco ;
McDonagh, Theresa ;
Pierard, Luc A. ;
Trindade, Pedro T. ;
Zompatori, Maurizio ;
Hoeper, Marius .
EUROPEAN HEART JOURNAL, 2016, 37 (01) :67-+
[9]   COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension [J].
Hoeper, Marius M. ;
Pausch, Christine ;
Olsson, Karen M. ;
Huscher, Doerte ;
Pittrow, David ;
Gruenig, Ekkehard ;
Staehler, Gerd ;
Vizza, Carmine Dario ;
Gall, Henning ;
Distler, Oliver ;
Opitz, Christian ;
Gibbs, J. Simon R. ;
Delcroix, Marion ;
Ghofrani, H. Ardeschir ;
Park, Da-Hee ;
Ewert, Ralf ;
Kaemmerer, Harald ;
Kabitz, Hans-Joachim ;
Skowasch, Dirk ;
Behr, Juergen ;
Milger, Katrin ;
Halank, Michael ;
Wilkens, Heinrike ;
Seyfarth, Hans-Juergen ;
Held, Matthias ;
Dumitrescu, Daniel ;
Tsangaris, Iraklis ;
Vonk-Noordegraaf, Anton ;
Ulrich, Silvia ;
Klose, Hans ;
Claussen, Martin ;
Lange, Tobias J. ;
Rosenkranz, Stephan .
EUROPEAN RESPIRATORY JOURNAL, 2022, 60 (01)
[10]   Risk assessment in pulmonary arterial hypertension [J].
Hoeper, Marius M. ;
Pittrow, David ;
Opitz, Christian ;
Gibbs, J. Simon R. ;
Rosenkranz, Stephan ;
Gruenig, Ekkehard ;
Olsson, Karen M. ;
Huscher, Doerte .
EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (03)